comparemela.com

Latest Breaking News On - Australian stock exchange gtg ax - Page 1 : comparemela.com

Quarterly Activities Update: Encouraging Growth for

MELBOURNE, Australia, July 28, 2023 (GLOBE NEWSWIRE) Genetic Technologies Limited (NASDAQ:GENE, “Company”, “GTG”), a global leader in guideline-driven.

United statesSimon morrissErika spaethAdrian mulcahyGenetic technologiesExchange commissionBoard of genetic technologiesBiotechnology innovation organisationAmerican society of clinical oncologistsGenetic technologies limitedClinical medical affairsA national televisionTechnologies limitedQuarterly business updateType multi riskNational television

GeneType featured on U S National TV to raise Breast

MELBOURNE, Australia, May 23, 2023 (GLOBE NEWSWIRE) Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) a global leader in.

United statesJoel evansCarolynn youngGenetic technologies limitedAmerican cancer society facts figuresGenetic technologies ltdExchange commissionGenetic technologiesTechnologies limitedType breast cancer risk assessment testBalancing actBalancing act linkedinBreast cancerGenetype breast cancer test unitedCancer society factsAustralian stock exchange gtg ax

Quarterly Business Update – December 2022; Sixth

MELBOURNE, Australia, Jan. 30, 2023 (GLOBE NEWSWIRE) Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE,” Company”, “GTG”), a global leader in.

Genetic technologies limitedTechnologies limitedAustralian stock exchange gtg axGenetic technologies ltdGenetic technologiesDna testing

Genetic Technologies Provides Update on US Operations and

MELBOURNE, Australia, Sept. 02, 2022 (GLOBE NEWSWIRE) Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”, “GENE”), a global leader.

United statesGenetic technologies limitedTechnologies limitedMedicine practicesAustralian stock exchange gtg axGenetic technologies ltd

Genetic Technologies Reports Q1 FY22 Results

Genetype MultiTest submitted for regulatory approval as commercialization plans gather momentum increase in cash receipts over prior quarter .

United statesUnited kingdomBiobank gafniSimon morrissPredictive panel risk testInstitute of public health in st louisCompany multiGenetic technologies limitedTechnologies limitedBreast cancerColorectal cancerProstate cancerOvarian cancerCoronary artery diseaseAfrican americanPublic health

vimarsana © 2020. All Rights Reserved.